<DOC>
	<DOC>NCT01350921</DOC>
	<brief_summary>Study evaluates the drug-drug interaction between Ticagrelor and Venlafaxine when taken together in healthy volunteers</brief_summary>
	<brief_title>Evaluation of the Drug-drug Interaction Between Ticagrelor and Venlafaxine When Taken Together in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>a weight of at least 50 kg and a body mass index between 18 to 30 kg/m2 History of clinically significant disease or disorder as judged by the investigator Any clinically significant illness, medical/surgical procedure or trauma within 4 weeks of the first administration of drug. History of haemophilia, von WillebrandÂ´s disease, lupus anticoagulant or other diseases/syndromes that may alter or increase bleeding. History of previous or ongoing psychiatric disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>phase 1</keyword>
	<keyword>ticagrelor</keyword>
	<keyword>venlafaxine</keyword>
</DOC>